Microscopic and macroscopic models for the onset and progression of Alzheimer's disease
暂无分享,去创建一个
Andrea Tosin | Michiel Bertsch | Bruno Franchi | Maria Carla Tesi | M. Bertsch | A. Tosin | M. C. Tesi | B. Franchi
[1] M. Smoluchowski. Versuch einer mathematischen Theorie der Koagulationskinetik kolloider Lösungen , 1918 .
[2] T. L. Hill. Length dependence of rate constants for end-to-end association and dissociation of equilibrium linear aggregates. , 1983, Biophysical journal.
[3] R. Murphy,et al. Kinetics of aggregation of synthetic beta-amyloid peptide. , 1992, Archives of biochemistry and biophysics.
[4] Regina M. Murphy,et al. Kinetics of aggregation of synthetic β-amyloid peptide , 1992 .
[5] T. Good,et al. Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] M McNamara,et al. Aggregation and disaggregation of senile plaques in Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Goodhill. Diffusion in Axon Guidance , 1997, The European journal of neuroscience.
[8] W. Griffin,et al. Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.
[9] C. Nicholson,et al. Extracellular space structure revealed by diffusion analysis , 1998, Trends in Neurosciences.
[10] B Urbanc,et al. Dynamics of plaque formation in Alzheimer's disease. , 1999, Biophysical journal.
[11] Regina M. Murphy,et al. Probing the Kinetics of β-Amyloid Self-Association , 2000 .
[12] L. Edelstein-Keshet,et al. Exploring the formation of Alzheimer's disease senile plaques in silico. , 2002, Journal of theoretical biology.
[13] M. Meyer-Lühmann. Experimental approaches to study cerebral amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004 .
[14] M. Mattson. Erratum: Pathways towards and away from Alzheimer's disease (Nature (2004) 430 (631-639)) , 2004 .
[15] Vladimir I. Clue. Harmonic analysis , 2004, 2004 IEEE Electro/Information Technology Conference.
[16] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[17] Henrik Zetterberg,et al. Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.
[18] G. Toscani,et al. Kinetic models of opinion formation , 2006 .
[19] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[20] D. Selkoe,et al. Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.
[21] Agneta Nordberg,et al. Amyloid imaging in Alzheimer's disease , 2007, Neuropsychologia.
[22] D. Holtzman,et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.
[23] C. Jack,et al. Mild cognitive impairment: ten years later. , 2009, Archives of neurology.
[24] S. de Santi,et al. Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.
[25] D. Teplow,et al. Structure-neurotoxicity relationships of amyloid β-protein oligomers , 2009, Neuroscience Research.
[26] B. Strooper,et al. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.
[27] H. Braak,et al. Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.
[28] M. Weiner,et al. A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.
[29] G. E. Vates,et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.
[30] Eric M Reiman,et al. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study , 2012, The Lancet Neurology.
[31] J. Sérot,et al. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.
[32] R. Mayeux,et al. Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[33] Paco Martorell,et al. Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.
[34] Yves Achdou,et al. A qualitative model for aggregation and diffusion of $$\beta $$-amyloid in Alzheimer’s disease , 2013, Journal of mathematical biology.
[35] Laurent Pujo-Menjouet,et al. Alzheimer’s disease: analysis of a mathematical model incorporating the role of prions , 2013, Journal of mathematical biology.
[36] M. C. Tesi,et al. A QUALITATIVE MODEL FOR AGGREGATION-FRAGMENTATION AND DIFFUSION OF β-AMYLOID IN ALZHEIMER’S DISEASE , 2014 .
[37] Lorenzo Pareschi,et al. Reviews , 2014 .
[38] N. Bobkova,et al. Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties , 2015, Biochemistry (Moscow).
[39] Bruno Franchi,et al. From a Microscopic to a Macroscopic Model for Alzheimer Disease: Two-Scale Homogenization of the Smoluchowski Equation in Perforated Domains , 2016, J. Nonlinear Sci..
[40] Avner Friedman,et al. Mathematical model on Alzheimer’s disease , 2016, BMC Systems Biology.
[41] Andrea Tosin,et al. Alzheimer's disease: a mathematical model for onset and progression. , 2015, Mathematical medicine and biology : a journal of the IMA.
[42] B. Franchi,et al. Smoluchowski Equation with Variable Coefficients in Perforated Domains: Homogenization and Applications to Mathematical Models in Medicine , 2017 .